Author

Xiaofei Li

Observed institution: Hong Kong Baptist University

ORCID: 0000-0001-9276-5462

Observed ORCID: 0000-0001-9276-5462

OpenAlex ID: A5036173654

Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectives

2024 · Tao Xiaohui, Luyao Wang, et al. · Journal of Orthopaedic Translation · 11

Bioinformatic Analysis of PTTG Family and Prognosis and Immune Cell Infiltration in Gastric Cancer

2023 · Xiao Li, Yanghao Tai, et al. · Stem Cells International · 2

Cost-effectiveness of disitamab vedotin plus toripalimab versus chemotherapy alone as first-line treatment for HER2-overexpressing advanced urothelial carcinoma: a cost-effectiveness analysis from the Chinese healthcare system perspective

2026 · Yang Liu, Lin Qiao, et al. · Frontiers in Oncology

Development and validation of a machine learning-based prediction model for anemia risk in patients with primary lung cancer receiving platinum-based chemotherapy: a multicenter study

2026 · Kaining Zhang, Xiao Li, et al. · Frontiers in Oncology

Machine Learning Prediction of Prolonged Length of Stay in Older Patients with Lung Cancer: A Multicenter Study Using XGBoost with SHAP Interpretation

2026 · Xiao Li, Shuying Liu, et al. · Cancer Management and Research

Works count: 5

Citation count: 13

H-index: 2

I10-index: 1